Q4 2024 Management View CEO Jon Congleton highlighted the company's focus on advancing its pivotal trials for lorundrostat, targeting dysregulated aldosterone in patients with uncontrolled and ...
today outlines the design of new clinical trials within its Acute on-Chronic Liver Failure (ACLF) pipeline, with several clinical data readouts by end of 2025. Pascal Prigent, CEO of GENFIT ...
today outlines the design of new clinical trials within its Acute on-Chronic Liver Failure (ACLF) pipeline, with several clinical data readouts by end of 2025. New trials, set to launch ...
Demand for electric vehicles accelerated in January, with fully battery-powered cars outperforming an overall contraction in the car market that the industry blames on declining business and ...
Anyone who cares about receiving Social Security payments or Medicare needs to pay attention to the massive theft of our data and possibly our money. According to Reuters, “Elon Musk’s team ...
Hosted on MSN17d
BRF S.A. files 6-K with SEC, outlines forward-looking statementsAccording to InvestingPro data, the company has demonstrated strong performance with a 31.96% return over the past year. The document, which is a report for foreign private issuers, contains ...
CFO Kostakis projected net new money growth of approximately 3% for ... Without prior quarter data, notable developments included the increased focus on cost savings, with an extended program ...
DEERFIELD — As budget season begins to ramp up, Deerfield residents got a financial refresher Thursday evening at the first of several community conversations. Finance Committee Chair Julie ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback